Australia markets closed

Bluejay Diagnostics, Inc. (BJDX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5470+0.0092 (+1.71%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
249.04
0
0
Cost of revenue
0
0
200.129
0
-
Gross profit
0
0
48.911
0
-
Operating expenses
Research development
5,715
5,715
4,152
1,148
527.253
Selling general and administrative
4,597
4,597
5,215
2,082
669.138
Total operating expenses
10,311
10,311
9,367
3,155
1,196
Operating income or loss
-10,311
-10,311
-9,318
-3,155
-1,196
Interest expense
-
-
0
367.459
26.997
Total other income/expenses net
192.429
192.429
-68.845
34.324
65.103
Income before tax
-9,954
-9,954
-9,297
-3,488
-1,158
Income from continuing operations
-9,954
-9,954
-9,297
-3,488
-1,158
Net income
-9,954
-9,954
-9,297
-3,488
-1,158
Net income available to common shareholders
-9,954
-9,954
-9,297
-3,488
-1,158
Basic EPS
-9.64
-
-9.22
-8.20
-1.82
Diluted EPS
-9.64
-
-9.22
-8.20
-1.82
Basic average shares
1,039
-
1,008
426.121
634.713
Diluted average shares
1,039
-
1,008
426.121
634.713